SARS-CoV-2 encoded miRNA is a biomarker for stratification of severe patients
(Nanjing University School of Life Sciences) The multi-centre study identified a microRNA-like small RNA encoded by SARS-CoV-2 in the serum of COVID-19 patients, which can be developed as a non-invasive biomarker for stratification of severe patients from mild/moderate ones and for identification of high-risk individuals before clinical manifestation of severe symptoms. This biomarker ensures proper allocation of patients to different levels of medical facilities and allows more effective control of the pandemic and relief of social economic burdens.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: COVID-19 | Infectious Diseases | Pandemics | SARS | Study